High Tower Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

High Tower Advisors, LLC

  • $64.2 Billion
  • Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, High Tower Advisors, LLC holds 26,451 shares of TEVA stock, worth $452,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,451
Previous 27,354 3.3%
Holding current value
$452,576
Previous $385,000 11.43%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$12.78 - $17.4 $11,540 - $15,712
-903 Reduced 3.3%
26,451 $429,000
Q1 2024

May 06, 2024
BUY
$10.67 - $14.43 $1,152 - $1,558
108 Added 0.4%
27,354 $385,000
Q4 2023

Feb 12, 2024
SELL
$8.12 - $10.63 $43,393 - $56,806
-5,344 Reduced 16.4%
27,246 $284,000
Q3 2023

Nov 08, 2023
BUY
$7.48 - $10.7 $3,179 - $4,547
425 Added 1.32%
32,590 $332,000
Q2 2023

Aug 14, 2023
SELL
$7.2 - $9.47 $1.09 Million - $1.43 Million
-150,834 Reduced 82.42%
32,165 $242,000
Q1 2023

May 11, 2023
SELL
$8.36 - $11.37 $923,061 - $1.26 Million
-110,414 Reduced 37.63%
182,999 $1.62 Million
Q4 2022

Feb 08, 2023
SELL
$7.95 - $9.48 $139,927 - $166,857
-17,601 Reduced 5.66%
293,413 $2.68 Million
Q3 2022

Nov 09, 2022
SELL
$6.86 - $11.95 $515,302 - $897,648
-75,117 Reduced 19.45%
311,014 $2.5 Million
Q2 2022

Aug 10, 2022
BUY
$7.38 - $10.4 $425,582 - $599,736
57,667 Added 17.56%
386,131 $2.91 Million
Q1 2022

May 12, 2022
BUY
$7.33 - $9.39 $731,072 - $936,530
99,737 Added 43.61%
328,464 $3.08 Million
Q4 2021

Feb 10, 2022
SELL
$7.9 - $10.19 $217,645 - $280,734
-27,550 Reduced 10.75%
228,727 $1.83 Million
Q3 2021

Nov 12, 2021
BUY
$8.38 - $10.18 $1.68 Million - $2.04 Million
200,640 Added 360.62%
256,277 $2.5 Million
Q2 2021

Aug 06, 2021
BUY
$9.9 - $11.56 $14,097 - $16,461
1,424 Added 2.63%
55,637 $554,000
Q1 2021

May 10, 2021
BUY
$10.34 - $12.81 $62,412 - $77,321
6,036 Added 12.53%
54,213 $631,000
Q4 2020

Feb 10, 2021
BUY
$8.61 - $11.04 $113,324 - $145,308
13,162 Added 37.59%
48,177 $466,000
Q3 2020

Nov 13, 2020
SELL
$8.57 - $12.69 $1,456 - $2,157
-170 Reduced 0.48%
35,015 $318,000
Q2 2020

Aug 10, 2020
BUY
$8.12 - $13.12 $5,277 - $8,528
650 Added 1.88%
35,185 $431,000
Q1 2020

May 21, 2020
BUY
$6.69 - $13.45 $25,221 - $50,706
3,770 Added 12.25%
34,535 $307,000
Q4 2019

Feb 14, 2020
SELL
$6.53 - $10.72 $53,467 - $87,775
-8,188 Reduced 21.02%
30,765 $302,000
Q3 2019

Nov 12, 2019
SELL
$6.16 - $9.6 $135,396 - $211,008
-21,980 Reduced 36.07%
38,953 $261,000
Q2 2019

Aug 13, 2019
BUY
$8.12 - $15.72 $162,741 - $315,060
20,042 Added 49.01%
60,933 $564,000
Q1 2019

May 15, 2019
SELL
$15.58 - $20.01 $34,322 - $44,082
-2,203 Reduced 5.11%
40,891 $648,000
Q4 2018

Feb 14, 2019
SELL
$14.59 - $23.84 $247,533 - $404,469
-16,966 Reduced 28.25%
43,094 $665,000
Q3 2018

Nov 09, 2018
SELL
$21.06 - $25.65 $1.56 Million - $1.9 Million
-74,253 Reduced 55.28%
60,060 $1.29 Million
Q2 2018

Aug 14, 2018
BUY
$16.77 - $24.71 $1.38 Million - $2.03 Million
82,092 Added 157.2%
134,313 $3.25 Million
Q1 2018

May 15, 2018
SELL
$16.68 - $22.07 $85,902 - $113,660
-5,150 Reduced 8.98%
52,221 $890,000
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $295,753 - $503,017
-26,336 Reduced 31.46%
57,371 $1.09 Million
Q3 2017

Nov 14, 2017
SELL
$15.41 - $32.17 $3.87 Million - $8.08 Million
-251,229 Reduced 75.01%
83,707 $1.48 Million
Q2 2017

Aug 14, 2017
BUY
N/A
334,936
334,936 $11.1 Million

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
565M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email